Anatomo-pathological analysis after CoreValve Revalving system implantation

EuroIntervention

Volumn 5, Issue 1, 2009, Pages 78-85

  Noble, Stéphane ^a   Asgar, Anita ^a   Cartier, Raymond ^a   Virmani, Renu ^b   Bonan, Raoul ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b CVPATH INSTITUTE   (United States)

Author keywords

CoreValve Revalving System; Pathological analysis; Percutaneous aortic valve replacement

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRIN; HEPARIN;

ADULT; AGED; AORTA FLOW; AORTA INTIMA; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; AORTA WALL; ARTICLE; AUTOPSY; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LOADING DRUG DOSE; MALE; MORTALITY; OUTCOME ASSESSMENT; PATHOLOGICAL ANATOMY; PATIENT SAFETY;

EID: 74249113435     PISSN: 1774024X     EISSN: None     Source Type: Journal    
DOI: 10.4244/EIJV5I1A12     Document Type: Article

References (12)

1. Lung B, Baron G, Butchart E, Delahaye F, Gohlke-Barwolf C, Levang O, Tornos P, Vanoverschelde J, Vermeer F, Boersma E, Ravaud P and Vahanian A. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231-1243.
2. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron Christophe, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon M. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenos: First Human Case Description Circulation. 2002;106:3006-3008.
3. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755-763.
4. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50: 69-76.
5. Piazza N, Grube E, Greckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde J-C, de Jaegere P, Serruys P. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:1, 242-249.
6. Schoen F. Pathology of Heart Valve Substitution With Mechanical and Tissue Prosthesis. In: Silver M, Gotlieb A, Schoen F. (eds). Cardiovascular Pathology, 3rd ed. Philadelphia Churchill Livingstone 2001, p 637.
7. Berry C, Cartier R, Bonan R. Fatal Ischemic Stroke Related to Nonpermissive Peripheral Artery Access for Percutaneous Aortic Valve Replacement. Catheter Cardiovasc Interv. 2007;69:59-63.
8. Berry C, Asgar A, Lamarche Y, Marcheix B, Couture P, Basmadjian A, Ducharme A, Laborde JC, Cartier R, Bonan R. Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System. Catheter Cardiovasc Interv. 2007 Oct 1;70(4):610-6.
9. Walley V, Ascah K. Massive cardiac deposits of AL-amyloid in a patient with previous valve replacement. J Heart Valve Dis. 1994 Mar; 3(2): 220-3.
10. Linke A, llriegel R, Walther T, Schierle K, Wittekind C, Ender J, Mohr F, Schuler G: Ingrowths of a Percutaneously Implanted Aortic Valve Prosthesis (CoreValve) in a Patient With Severe Aortic Stenosis. Circ Cardiovasc Intervent. 2008;1;155-158.
11. Nordmeyer J, Khambadkone S, Coats L, Schievano S, Lurz P, Parenzan G, Taylor AM, Lock JE, Bonhoeffer P. Risk stratification, systematic classification, and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation. 2007;115(11):1392-7.
12. Wenaweser P, Buellesfeld L, Gerckens U, Grube E. Percutaneous Aortic Valve Replacement for Severe Aortic Regurgitation in Degenerated Bioprosthesis: The First Valve in Valve Procedure Using the CoreValve Revalving System. Catheter Cardiovasc Interv. 2007;70:760-764.